Prescribing information



Welcome to the Entresto On-demand webinars page. Below you can access recordings from two educational webinars that were hosted by experts in the field of heart failure and were organised by Novartis. You will find full recordings, enabling you to listen to two webinars, covering the management of patients with chronic heart failure.

You will be required to register to watch the videos.


What can I do to keep my chronic HFrEF patients out of hospital?

Watch Jacqui Hyland, Dr Matt Fay and Dr Simon Williams discuss chronic heart failure management in primary care.



Early initiation of Entresto® (sacubitril/valsartan): alter the cycle of readmission in patients with heart failure

Watch Dr Aaron Wong present key findings from two studies in treatment of patients with chronic heart failure.



Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1

HFrEF, heart failure with reduced ejection fraction.


  1. Entresto Summary of Product Characteristics, 2020.
ENT20-C046(2)f October 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]